FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


13129 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) est un(e) (attribut) Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Glucose 20% infusion solution 500 mL polyethylene bottle (product) Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Glucose 20% infusion solution bottle (product) Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Glucose 40% infusion solution bottle (product) Glucose 400 mg/mL solution for injection
Glucose 50% infusion solution bottle (product) Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Glucose 50% injection solution prefilled syringe (product) Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Glucose 70% infusion solution bag (product) Product containing precisely glucose 200 milligram/1 milliliter conventional release solution for injection (clinical drug)
Gluphosphate causing toxic effect Glyphosate toxicity
Glycerin 10% conventional release eye drops Glycerin 10 mg/mL eye solution
Glycerin 10% preservative-free eye drops (product) Glycerin 10 mg/mL eye solution
Glycerin 20% conventional release eye drops Product containing only glycerol in ocular dose form (medicinal product form)
Glycerin 20% preservative-free eye drops (product) Product containing only glycerol in ocular dose form (medicinal product form)
Glycerin 30% conventional release eye drops Product containing only glycerol in ocular dose form (medicinal product form)
Glycerin 30% preservative-free eye drops (product) Product containing only glycerol in ocular dose form (medicinal product form)
Glycerin 50% conventional release eye drops Glycerin 500 mg/mL eye solution
Glycerin 50% preservative-free eye drops (product) Glycerin 500 mg/mL eye solution
Glycerin 50% solution (product) Product containing only glycerol (medicinal product)
Glycerol 1g infant suppository (product) Product containing precisely glycerol 1 gram/1 each conventional release rectal suppository (clinical drug)
Glycerol 2g child suppository (product) Glycerin 2 g rectal suppository
Glycerol 4g adult suppository (product) Product containing precisely glycerol 4 gram/1 each conventional release rectal suppository (clinical drug)
Glycerol kinase deficiency (disorder) Deficiency of glycerol kinase
Glyceryl trinitrate 0.4% ointment (product) Nitroglycerin only product
Glyceryl trinitrate 2mg m/r buccal tablet (product) Product containing precisely glyceryl trinitrate 2 milligram/1 each conventional release buccal tablet (clinical drug)
Glyceryl trinitrate 3mg m/r buccal tablet (product) Product containing precisely glyceryl trinitrate 3 milligram/1 each conventional release buccal tablet (clinical drug)
Glyceryl trinitrate 5mg m/r buccal tablet (product) Nitroglycerin 5 mg buccal tablet
Glyceryl trinitrate spray allergy Allergy to nitroglycerin
Glycosidase Glycosidase
Glycosyltransferase Glycosyltransferase
Goat's milk (product) Goat's milk
Gomphocarpus physocarpus Asclepias physocarpus (organism)
Gomphrena physocarpus Asclepias physocarpus (organism)
Gorissenne's sign Jorissenne sign
Goura cristata cristata (organism) Goura cristata (organism)
Gout with other manifestation, NEC Gout
Gouty nephropathy NOS néphropathie goutteuse chronique
Gouty nephropathy unspecified néphropathie goutteuse chronique
Grade of dysplasia of adenoma at surgical proximal margin (observable entity) Histologic grade of dysplasia at proximal surgical margin
Grafting of bone, autogenous or bone bank (procedure) Bone graft
Grafting of nasolabial flaps (procedure) Reconstruction using nasolabial flap of skin (procedure)
Grafting of pedicle fascial flap (procedure) Reconstruction using pedicle fascial flap (procedure)
Grafting of posterior tibial flap Reconstruction using posterior tibial artery fasciocutaneous flap
Grafting of tarsal or metatarsal (procedure) Grafting of phalanges of foot
Grahamella Bartonella
Grahamella peromysci Bartonella peromysci
Grahamella species Bartonella
Grahamella talpae Bartonella peromysci
Grahamellosis Bartonellosis
hyphe Gram positif ramifié et filamenteux (organisme) Gram-positive branched filamentous bacilli present (finding)
Granuloma of lacrimal passages Lacrimal sac granuloma
Granulovacuolar degeneration of Simchowicz Granulovacuolar degeneration
Graphosid spider Order Araneae (organism)
Grey elder pollen Grey alder pollen (substance)
Great toe flap Flap (substance)
Great vessel repair with unlisted major procedure Repair of great vessels
Greenfield filter Vena cava filter
Griseofulvin, microsize 125mg/5mL suspension (product) Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug)
Griseofulvin, microsize 125mg/mL suspension (product) Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug)
Groin flap Flap (substance)
Gross stress reaction (disorder) Acute stress disorder
Guaiac test (procedure) Chemical test for occult blood
Guaifenesin + oxtriphylline 50mg/100mg elixir (product) Product containing only guaifenesin and theophylline in oral dose form (medicinal product form)
Guaifenesin + theophylline sodium glycinate 100mg/300mg elixir (product) Product containing only guaifenesin and theophylline in oral dose form (medicinal product form)
Guaifenesin 100mg/5ml syrup (product) Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug)
Guaifenesin 1200mg /dextromethorphan 60mg prolonged-release oral tablet Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet
Guaifenesin 1200mg /pseudoephedrine 120mg prolonged-release oral tablet (product) Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)
Guaifenesin 1200mg m/r tablet (product) Product containing only guaifenesin in oral dose form (medicinal product form)
Guaifenesin 1200mg m/r/dextromethorphan 60mg tablet (product) Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet
Guaifenesin 1200mg m/r/pseudoephedrine 120mg tablet (product) Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)
Guaifenesin 1200mg prolonged-release oral tablet Product containing only guaifenesin in oral dose form (medicinal product form)
Guaifenesin 300mg m/r capsule (product) Product containing only guaifenesin in oral dose form (medicinal product form)
Guaifenesin 300mg prolonged-release oral capsule (product) Product containing only guaifenesin in oral dose form (medicinal product form)
Guaifenesin 50mg/1mL (product) Product containing only guaifenesin (medicinal product)
Guaifenesin 600mg /dextromethorphan 30mg prolonged-release oral tablet (product) Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)
Guaifenesin 600mg /pseudoephedrine 60mg prolonged-release oral tablet Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)
Guaifenesin 600mg m/r capsule (product) Product containing only guaifenesin in oral dose form (medicinal product form)
Guaifenesin 600mg m/r/dextromethorphan 30mg tablet (product) Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)
Guaifenesin 600mg m/r/pseudoephedrine 60mg tablet (product) Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)
Guaifenesin 600mg prolonged-release oral capsule Product containing only guaifenesin in oral dose form (medicinal product form)
Guanethidine monosulfate 0.25% eye drops (product) Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Guanethidine monosulfate 0.5% eye drops (product) Guanethidine 5 mg/mL eye solution
Guanethidine monosulfate 1% eye drops (product) Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug)
Guanethidine monosulfate 2% eye drops (product) Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug)
Guanethidine monosulfate 3% eye drops (product) Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug)
Guanethidine monosulfate+epinephrine 0.25%/0.05% eye drops (product) Product containing precisely epinephrine (as epinephrine bitartrate) 500 microgram/1 milliliter and guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Guanethidine monosulfate+epinephrine 0.5%/0.1% eye drops (product) Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/1 milliliter and guanethidine 5 milligram/1 milliliter conventional release eye solution (clinical drug)
Guanethidine monosulfate+epinephrine 1%/0.5% eye drops (product) Epinephrine (as epinephrine bitartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution
Guanfacine hydrochloride 1.0mg tablet (product) Guanfacine (as guanfacine hydrochloride) 1 mg oral tablet
Guanfacine hydrochloride 1mg extended release tablet (product) Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug)
Guanfacine hydrochloride 2mg extended release tablet (product) Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug)
Guanfacine hydrochloride 3mg extended release tablet (product) Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug)
Guanfacine hydrochloride 4mg extended release tablet (product) Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet
Guide wire placement via previous catheter action : insertion
Gummata of yaws (disorder) Nodular late yaws
Gummatous frambeside Nodular late yaws
Gunstock deformity Acquired cubitus varus
Gunther temporary caval filter Temporary vena cava filter
Gynecological laparoscopy NEC Laparoscopy of female pelvis
H/O: cat allergy (finding) Allergy to Felis catus protein (finding)
H/O: cat allergy (finding) Allergy to Felis catus protein (finding)
HPV - Human papillomavirus test declined Screening for Human papillomavirus declined (situation)
HPV - Human papillomavirus test declined Screening for Human papillomavirus declined (situation)
HTLV 2 nucleic acid detection HTLV 2 nucleic acid assay

Start Previous Page 42 of 132 Next End


Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start